全文获取类型
收费全文 | 16322篇 |
免费 | 1412篇 |
国内免费 | 72篇 |
专业分类
耳鼻咽喉 | 228篇 |
儿科学 | 365篇 |
妇产科学 | 238篇 |
基础医学 | 1945篇 |
口腔科学 | 468篇 |
临床医学 | 1783篇 |
内科学 | 3741篇 |
皮肤病学 | 281篇 |
神经病学 | 1207篇 |
特种医学 | 766篇 |
外科学 | 2451篇 |
综合类 | 407篇 |
现状与发展 | 30篇 |
一般理论 | 16篇 |
预防医学 | 1201篇 |
眼科学 | 517篇 |
药学 | 1095篇 |
中国医学 | 43篇 |
肿瘤学 | 1024篇 |
出版年
2023年 | 223篇 |
2021年 | 205篇 |
2020年 | 157篇 |
2019年 | 216篇 |
2018年 | 266篇 |
2017年 | 216篇 |
2016年 | 251篇 |
2015年 | 308篇 |
2014年 | 484篇 |
2013年 | 732篇 |
2012年 | 855篇 |
2011年 | 935篇 |
2010年 | 573篇 |
2009年 | 565篇 |
2008年 | 910篇 |
2007年 | 1050篇 |
2006年 | 1043篇 |
2005年 | 1010篇 |
2004年 | 1059篇 |
2003年 | 977篇 |
2002年 | 995篇 |
2001年 | 145篇 |
2000年 | 103篇 |
1999年 | 188篇 |
1998年 | 224篇 |
1997年 | 210篇 |
1996年 | 175篇 |
1995年 | 218篇 |
1994年 | 171篇 |
1993年 | 179篇 |
1992年 | 95篇 |
1991年 | 98篇 |
1990年 | 105篇 |
1989年 | 117篇 |
1988年 | 121篇 |
1987年 | 92篇 |
1986年 | 91篇 |
1985年 | 121篇 |
1984年 | 164篇 |
1983年 | 143篇 |
1982年 | 216篇 |
1981年 | 226篇 |
1980年 | 171篇 |
1979年 | 86篇 |
1978年 | 115篇 |
1977年 | 141篇 |
1976年 | 142篇 |
1975年 | 122篇 |
1974年 | 94篇 |
1973年 | 90篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Inna Y. Gong Nigel S. Tan Sammy H. Ali Gerald Lebovic Muhammad Mamdani Shaun G. Goodman Dennis T. Ko Andreas Laupacis Andrew T. Yan 《The Canadian journal of cardiology》2019,35(5):653-660
Background
Although it is known that women do not participate in trials as frequently as men, there are limited recent data examining how women recruitment has changed over time.Methods
We conducted MEDLINE search using a validated strategy for randomized trials published in New England Journal of Medicine, Lancet, and Journal of the American Medical Association between 1986 and 2015, and included trials evaluating pharmacologic or nonpharmacologic therapies. We abstracted data on demographics, intervention type, clinical indication, and trial design characteristics, and examined their relationships with women enrollment.Results
In total, 598 trials met inclusion criteria. Women enrollment increased significantly over time (21% between 1986 and 1990 to 33% between 2011 and 2015; Pfor trend < 0.001) and did not differ by journal or funding source. Women enrollment varied with clinical indication, comprising 37% for non–coronary artery disease vascular trials, 30% for coronary artery disease trials, 28% for heart failure trials, and 28% for arrhythmia trials (P < 0.001), which were all significantly lower than the expected proportion in disease populations (P < 0.001). Women enrollment varied with trial type (31%, 29%, and 26% for pharmacologic, device, and procedural trials, respectively; P = 0.001). These findings were corroborated using multivariable analysis. We found significant positive correlations between women enrolled, and mean age and total number of participants. Fewer women were enrolled in trials reporting statistically significant results than those who did not (P = 0.001).Conclusions
Although enrollment of women has increased over time, it remains lower than the relative proportion in the disease population. Future studies should elucidate the reasons for persistent under-representation of women in clinical trials. 相似文献3.
Gerald Chi Adeel Jamil Umer Jamil Muhammad A. Balouch Jolanta Marszalek Farima Kahe 《Clinical and experimental hypertension (New York, N.Y. : 1993)》2019,41(2):160-167
Background: Intensive blood pressure (BP) lowering may offer protective effects against major adverse cardiac event (MACE) but is also associated with a greater risk of a serious adverse event (SAE). The risk-benefit profile of intensive versus standard BP control has not been comprehensively assessed. Methods: Four studies were identified from a systematic literature search for randomized controlled trials comparing intensive versus standard BP lowering that reported both MACE and SAE endpoints. A previously described statistical approach was applied to characterize the efficacy-safety tradeoff of BP control. The bivariate outcome was computed to quantitatively assess the net clinical benefit (NCB) of intensive BP lowering as compared to standard treatment, with positive values indicating increased risks and negative values indicating decreased risks. Results: Data from the SPRINT trial demonstrated that intensive strategy was superior in MACE but inferior in SAE, thereby eroding the NCB (bivariate outcome: 0.33% [?0.50% to 1.21%]). Intensive strategy from the SPS3 trial fulfilled non-inferiority in both MACE and SAE but did not reach a favorable NCB (?1.31% [?2.25% to 0.01%]). The ACCORD trial suggested that intensive strategy was non-inferior in MACE but inferior in SAE (?0.19% [?0.79% to 1.37%]). Results from the VALISH trial were inconclusive for SAE but suggested non-inferiority in MACE (?1.19% [?3.24% to 0.68%]). Conclusions: Compared to the standard blood pressure target, pooled data from randomized controlled trials suggest that intensive strategy did not achieve a net clinical benefit when weighing the benefit of MACE reduction against the risk of SAE under the bivariate framework.Abbreviations: Blood pressure (BP), diastolic blood pressure (DBP), major adverse cardiac event (MACE), net clinical benefit (NCB), serious adverse event (SAE), systolic blood pressure (SBP). 相似文献
4.
We report on four children born with medium to large congenital melanocytic nevi (CMN) with color heterogeneity and irregular surface rugosity. As these patients aged, their nevi evolved to become more homogeneous and lighter in color, and developed a smoother, more even texture. We propose that given this evolution toward benignity, conservative monitoring and management may be appropriate even in the context of atypical‐appearing features at birth. Such knowledge regarding the evolution of these CMN can more accurately guide parents and clinicians in determining whether to biopsy or remove an atypical‐looking lesion early in life for medical or cosmetic reasons. 相似文献
5.
6.
7.
Javier Jarazo PhD Kyriaki Barmpa MSc Jennifer Modamio PhD Cláudia Saraiva PhD Sònia Sabaté-Soler MSc Isabel Rosety MSc Anne Griesbeck PhD Florian Skwirblies BSc Gaia Zaffaroni PhD Lisa M. Smits PhD Jihui Su BSc Jonathan Arias-Fuenzalida PhD Jonas Walter PhD Gemma Gomez-Giro PhD Anna S. Monzel PhD Xiaobing Qing PhD Armelle Vitali MSc Gerald Cruciani MSc Ibrahim Boussaad PhD Francesco Brunelli PhD Christian Jäger PhD Aleksandar Rakovic PhD Wen Li PhD Lin Yuan PhD Emanuel Berger PhD Giuseppe Arena PhD Silvia Bolognin PhD Ronny Schmidt PhD Christoph Schröder PhD Paul M.A. Antony PhD Christine Klein MD Rejko Krüger MD Philip Seibler PhD Jens C. Schwamborn PhD 《Movement disorders》2022,37(1):80-94
8.
9.
Amy Y. Zhang Christopher Burant Alex Z. Fu Gerald Strauss Donald R. Bodner Lee Ponsky 《Journal of psychosocial oncology》2020,38(2):210-227
AbstractPurpose: We examined underlying psychosocial processes of a behavioral treatment for urinary incontinence (UI) of prostate cancer survivors.Design: Secondary analysis of data collected from a clinical trial.Sample: Two hundred forty-four prostate cancer survivors who participated in a clinical trial of behavioral intervention to UI as intervention or control subjects.Methods: The participants had a 3-month behavioral intervention or usual care and were followed up for an additional 3?months. They were assessed at baseline, 3, and 6?months. Latent growth curve models were performed to examine trajectories of each study variable and relationships among the variables.Findings: Increasing self-efficacy and social support were significantly and independently associated with more reduction of urinary leakage frequency over time.Implications for psychosocial oncology: Providing problem-solving skills and social support, including peer support, are essential for empowering patients to reduce UI. 相似文献
10.
Pagaling Gerald T. Espiritu Adrian I. Dellosa Marie Antoinette A. Leochico Carl Froilan D. Pasco Paul Matthew D. 《Neurological sciences》2022,43(2):811-819
Neurological Sciences - The practice of teleneurology provided an accessible and safe method of consultation during the COVID-19 pandemic. We aimed to describe the practice of teleneurology among... 相似文献